243 related articles for article (PubMed ID: 35725460)
1. Dysferlinopathy misdiagnosed with juvenile polymyositis in the pre-symptomatic stage of hyperCKemia: a case report and literature review.
Contreras-Cubas C; Barajas-Olmos F; Frayre-Martínez MI; Siordia-Reyes G; Guízar-Sánchez CC; García-Ortiz H; Orozco L; Baca V
BMC Med Genomics; 2022 Jun; 15(1):139. PubMed ID: 35725460
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes.
Nguyen K; Bassez G; Krahn M; Bernard R; Laforêt P; Labelle V; Urtizberea JA; Figarella-Branger D; Romero N; Attarian S; Leturcq F; Pouget J; Lévy N; Eymard B
Arch Neurol; 2007 Aug; 64(8):1176-82. PubMed ID: 17698709
[TBL] [Abstract][Full Text] [Related]
3. ["Therapy-resistant polymyositis" - is the diagnosis correct?].
Ceccon G; Lehmann HC; Neuen-Jacob E; Meng G; Fink GR; Wunderlich G
Z Rheumatol; 2017 Sep; 76(7):640-643. PubMed ID: 28523511
[TBL] [Abstract][Full Text] [Related]
4. Limb-girdle muscular dystrophy type 2B misdiagnosed as polymyositis at the early stage: Case report and literature review.
Xu C; Chen J; Zhang Y; Li J
Medicine (Baltimore); 2018 May; 97(21):e10539. PubMed ID: 29794729
[TBL] [Abstract][Full Text] [Related]
5. The clinical, myopathological, and molecular characteristics of 26 Chinese patients with dysferlinopathy: a high proportion of misdiagnosis and novel variants.
Wang N; Han X; Hao S; Han J; Zhou X; Sun S; Tang J; Lu Y; Wu H; Ma S; Song X; Ji G
BMC Neurol; 2022 Nov; 22(1):398. PubMed ID: 36319958
[TBL] [Abstract][Full Text] [Related]
6. Recurrent, non-traumatic, non-exertional rhabdomyolysis after immunologic stimuli in a healthy adolescent female: a case report.
Katz J; Labilloy A; Lee A
BMC Pediatr; 2022 Aug; 22(1):515. PubMed ID: 36042458
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous characteristics of Korean patients with dysferlinopathy.
Park HJ; Hong JM; Suh GI; Shin HY; Kim SM; Sunwoo IN; Suh BC; Choi YC
J Korean Med Sci; 2012 Apr; 27(4):423-9. PubMed ID: 22468107
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and genotypic analysis of limb-Girdle muscular dystrophy type 2B.
Aldosari KH; Al-Ghamdi S; Alkhathlan KM; Alkhalidi HM
Neurosciences (Riyadh); 2020 Jul; 25(3):214-217. PubMed ID: 32683403
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel heterozygous DYSF variant in a large family with a dominantly-inherited dysferlinopathy.
Folland C; Johnsen R; Botero Gomez A; Trajanoski D; Davis MR; Moore U; Straub V; Barresi R; Guglieri M; Hayhurst H; Schaefer AM; Laing NG; Lamont PJ; Ravenscroft G
Neuropathol Appl Neurobiol; 2022 Dec; 48(7):e12846. PubMed ID: 35962550
[TBL] [Abstract][Full Text] [Related]
10. Dysferlin deficiency treated like refractory polymyositis.
Vinit J; Samson M; Gaultier JB; Laquerriere A; Ollagnon E; Petiot P; Marie I; Levesque H; Rousset H
Clin Rheumatol; 2010 Jan; 29(1):103-6. PubMed ID: 19730931
[TBL] [Abstract][Full Text] [Related]
11. [Progressive muscular weakness of lower limbs revealing a limb girdle muscular dystrophy].
Saintmard G; Brands G; Debray FG; Lognard M
Rev Med Liege; 2017 Jul; 72(7-8):373-376. PubMed ID: 28795552
[TBL] [Abstract][Full Text] [Related]
12. Compound heterozygous DYSF variants causing limb-girdle muscular dystrophy type 2B in a Chinese family.
Li L; Jing Z; Cheng L; Liu W; Wang H; Xu Y; Zheng X; Yu X; Liu S
J Gene Med; 2020 Nov; 22(11):e3272. PubMed ID: 32889728
[TBL] [Abstract][Full Text] [Related]
13. [Dysferlin expression in limb-girdle muscular dystrophy and Miyoshi myopathy: analysis of 45 cases].
Ren SC; Yan CZ; Li MX; Liu SP; Wu JL; Zhao YY; Li W; Li DN
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1486-90. PubMed ID: 17785089
[TBL] [Abstract][Full Text] [Related]
14. [Dysferlinopathy masquerading as a refractory polymyositis].
Loureiro Amigo J; Gallardo E; Gallano P; Grau-Junyent JM
Med Clin (Barc); 2015 Nov; 145(9):414-5. PubMed ID: 25662721
[No Abstract] [Full Text] [Related]
15. Diagnosis by protein analysis of dysferlinopathy in two patients mistaken as polymyositis.
Angelini C; Grisold W; Nigro V
Acta Myol; 2011 Dec; 30(3):185-7. PubMed ID: 22616201
[TBL] [Abstract][Full Text] [Related]
16. Late-onset dysferlinopathy presented as "liver enzyme" abnormalities: a technical note.
Li F; Yin G; Xie Q; Shi G
J Clin Rheumatol; 2014 Aug; 20(5):275-7. PubMed ID: 25036559
[TBL] [Abstract][Full Text] [Related]
17. CD4+ cells, macrophages, MHC-I and C5b-9 involve the pathogenesis of dysferlinopathy.
Yin X; Wang Q; Chen T; Niu J; Ban R; Liu J; Mao Y; Pu C
Int J Clin Exp Pathol; 2015; 8(3):3069-75. PubMed ID: 26045819
[TBL] [Abstract][Full Text] [Related]
18. A Novel Homozygous Variant in DYSF Gene Is Associated with Autosomal Recessive Limb Girdle Muscular Dystrophy R2/2B.
Spadafora P; Qualtieri A; Cavalcanti F; Di Palma G; Gallo O; De Benedittis S; Cerantonio A; Citrigno L
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012197
[TBL] [Abstract][Full Text] [Related]
19. Miyoshi Muscular Dystrophy Type 1 with Mutated
Park J; Moon YJ; Kim DS
Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672942
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
